A French teen who was given gene therapy for sickle cell disease more than two years ago now has enough properly working red blood cells to dodge the effects of
Tag "Sickle Cell Disease"
Modus Therapeutics has raised €3.4M to support the completion of a Phase II trial for sickle cell disease, a painful condition with no cure. Modus Therapeutics, previously Dilaforette, is developing sevuparin,
Advertisements
